Pyrrolopyrazoles, potent kinase inhibitors

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 8530652
APP PUB NO 20120264751A1
SERIAL NO

13267302

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Pyrrole pyrazole compounds of formula I, compositions including these compounds and methods of their use are provided. Preferred compounds of formula I have activity as protein kinase inhibitors, including as inhibitors of PAK4.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
AGOURON PHARMACEUTICALS INCLA JOLLA CA

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Bouzida, Djamal San Diego, US 2 2
Dong, Liming San Diego, US 33 246
Guo, Chuangxing San Diego, US 12 186
Hong, Yufeng San Diego, US 32 440
Li, Haitao San Diego, US 383 1923
Marakovits, Joseph Timothy Encinitas, US 18 206
Yang, Anle San Diego, US 10 50
Zhang, Junhu San Diego, US 27 72

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Mar 10, 2025
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00